Canada Life
GSK icon

Canada Life’s GSK GSK Stock Holding History

Canada Life’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-928
Closed -$49K – 2490
2015
Q2 		$49K Buy
928
+320
+53% +$18K ﹤0.01% 2222
2015
Q1 		$40K Buy
608
+488
+407% +$28K ﹤0.01% 2187
2014
Q4 		$6K Buy
120
+80
+200% +$4.48K ﹤0.01% 2459
2014
Q3 		$2K Sell
40
-28,332
-100% -$1.74M ﹤0.01% 2483
2014
Q2 		$1.89M Buy
28,372
+372
+1% +$25.2K 0.01% 790
2014
Q1 		$1.86M Buy
28,000
+640
+2% +$43.3K 0.01% 790
2013
Q4 		$1.83M Buy
27,360
+720
+3% +$46.7K 0.01% 792
2013
Q3 		$1.67M Buy
26,640
+320
+1% +$20.6K 0.01% 754
2013
Q2 		$1.65M Buy
+26,320
New +$1.67M 0.01% 432

Other funds holding GSK

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Canada Life's GSK Position: Q3 2015 in Review

Canada Life sold out of GSK (GSK) in Q3 2015, closing a stake of 928 shares — an estimated $49K sold.

Canada Life first reported a position in GSK in Q2 2013 and held it in 9 quarters. The position peaked at $1.89M in Q2 2014. 706 funds tracked by Wall St. Rank hold GSK as of Q3 2015.

  • Canada Life reported no remaining GSK position as of Q3 2015 after selling out during the quarter.
  • Canada Life sold 928 GSK shares in Q3 2015, an estimated $49K.
  • Canada Life first reported a position in GSK in Q2 2013 and held it in 9 quarters.
  • Canada Life's GSK position peaked at $1.89M in Q2 2014.
  • 706 funds tracked by Wall St. Rank held GSK as of Q3 2015.

Based on Canada Life's 13F filing for Q3 2015, filed 10 Nov 2015.